中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2015年
9期
1309-1312
,共4页
崔燕平%崔霞%管珊%李庆方%王思奎
崔燕平%崔霞%管珊%李慶方%王思奎
최연평%최하%관산%리경방%왕사규
肝衰竭%肝性脑病%因素分析,统计学
肝衰竭%肝性腦病%因素分析,統計學
간쇠갈%간성뇌병%인소분석,통계학
Liver failure%Hepatic encephalopathy%Factor analysis,statistical
目的 对影响慢加急性肝衰竭(ACLF)伴肝性脑病(HE)患者预后的因素进行分析,探讨影响预后的危险因素.方法 回顾性分析159例ACLF伴HE患者的临床资料,以确定HE为起点,将患者分为生存组(13例)和死亡组(146例),选择32个相关临床指标,用SPSS软件对相关数据进行单因素和多因素非比例风险的Cox模型分析.结果 ACLF伴HE患者1、3、6个月的生存率分别为20.13%、10.06%、8.18%,经Cox回归分析,筛选出HE分期、肝肾综合征(HRS)为独立的预后因素(x2=18.344、11.368,均P<0.05),HE分期越高、出现HRS增加患者死亡风险,相对危险度(RR)分别为1.591、1.809.结论 HE分期、HRS是判断ACLF伴HE患者预后的重要指标.
目的 對影響慢加急性肝衰竭(ACLF)伴肝性腦病(HE)患者預後的因素進行分析,探討影響預後的危險因素.方法 迴顧性分析159例ACLF伴HE患者的臨床資料,以確定HE為起點,將患者分為生存組(13例)和死亡組(146例),選擇32箇相關臨床指標,用SPSS軟件對相關數據進行單因素和多因素非比例風險的Cox模型分析.結果 ACLF伴HE患者1、3、6箇月的生存率分彆為20.13%、10.06%、8.18%,經Cox迴歸分析,篩選齣HE分期、肝腎綜閤徵(HRS)為獨立的預後因素(x2=18.344、11.368,均P<0.05),HE分期越高、齣現HRS增加患者死亡風險,相對危險度(RR)分彆為1.591、1.809.結論 HE分期、HRS是判斷ACLF伴HE患者預後的重要指標.
목적 대영향만가급성간쇠갈(ACLF)반간성뇌병(HE)환자예후적인소진행분석,탐토영향예후적위험인소.방법 회고성분석159례ACLF반HE환자적림상자료,이학정HE위기점,장환자분위생존조(13례)화사망조(146례),선택32개상관림상지표,용SPSS연건대상관수거진행단인소화다인소비비례풍험적Cox모형분석.결과 ACLF반HE환자1、3、6개월적생존솔분별위20.13%、10.06%、8.18%,경Cox회귀분석,사선출HE분기、간신종합정(HRS)위독립적예후인소(x2=18.344、11.368,균P<0.05),HE분기월고、출현HRS증가환자사망풍험,상대위험도(RR)분별위1.591、1.809.결론 HE분기、HRS시판단ACLF반HE환자예후적중요지표.
Objective To analyze the prognostic factors for patients with hepatic encephalopathy (HE) in acute-on-chronic liver failure(ACLF).Methods A retrospective analysis was performed on 159 ACLF patients with HE.The hepatic encephalopathy was determined to baseline,the patients were divided into survivors(n =13) and nonsurvivors(n =146),The 32 factors affecting the prognosis were analyzed by Cox proportional hazard model with SPSS.Results One-month,three-month,and six-month survival rates were 20.13%,10.06% and 8.18%,respectively.Cox regression analysis of prognostic factors showed that it could the stage of hepatic encephalopathy and HRS significantly improve the survival rate of the patients with HE in acute-on-chronic liver failure.The stage of hepatic encephalopathy and HRS could significantly decrease the survival rate of the patients(x2 =18.344,11.368,all P < 0.05),elevated the levels of hepatic encephalopathy (relative risk (RR) =1.591) and HRS (RR =1.809) indicate worse prognosis with hepatic encephalopathy in acute-on-chronic failure.Conclusion The stage of hepatic encephalopathy and HRS were independent risk factor sof prognosis in acute-on-chronic liver failure.